Home › Macular Edema › Texas
Macular Edema clinical trials in Texas
5 studies for Macular Edema are looking for participants at sites in Texas.
Cities in Texas
- San Antonio5 studies
- The Woodlands4 studies
- Austin4 studies
- Houston3 studies
- Plano3 studies
- Cypress3 studies
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Austin Research Center for Retina ( Site 0033), Austin
- Austin Retina Associates ( Site 0008), Austin
- Retina Consultants of Texas ( Site 0001), Bellaire
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Texas Retina ( Site 0051), Arlington
- Texas Retina Associates ( Site 0055), Fort Worth
- Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100), Katy
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705607A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Austin Research Center for Retina, PLLC, Austin
- Austin Retina Associates, Austin
- Austin Clinical Research, LLC, Austin
- and 7 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06962839A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
- Retina Research Institute of Texas, Abilene
- Austin Retina Associates, PLLC (Austin), Austin
- UT Austin, Austin
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
- Retina Research Institute of Texas, Abilene
- Austin Retina Associates, PLLC (Austin), Austin
- UT Austin, Austin
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06996080From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.